Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Vernalis PLC Share Price
  4. Vernalis PLC Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksVernalis PLC Regulatory News (VER)

Vernalis PLC Information
  • There is currently no data for VER

Director/PDMR Shareholding

29 Dec 2008 10:00

RNS Number : 7651K
Vernalis PLC
29 December 2008
 



Vernalis PLC 

29 December 2008 

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS 

 

 

VERNALIS PLC 

 

 

WINNERSH, U.K 29th December 2008 Vernalis plc (LSE: VER) announces that in accordance with DTR 3.1.2R and  following a resolution by the Board of Vernalis plc passed in accordance with share scheme arrangements approved by shareholders, the following options over new ordinary shares of 5p each in the Company were today granted to the new Chief Executive Officer: 

 

 

Executive   No of shares Exercise Price % of Issued Share

Director under option Capital 

Ian Garland 9,750,000 5p 2.68% 

 

The options are exercisable between three and ten years following grant provided that the performance conditions of the option scheme are met.

 

 

Vernalis plc 

+44 (0) 118 977 3133 

Dr Peter Fellner

Executive Chairman 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPUGUGPUPRGUC
12345678910
Date   Source Headline
28th Apr 20177:00 amRNSTotal Voting Rights
26th Apr 20177:00 amRNSServier and Vernalis announce 3 milestones
21st Apr 20177:01 amRNSVernalis receives $2 million milestone payment
21st Apr 20177:00 amRNSFDA Issues Complete Response Letter on CCP-07 NDA
29th Mar 20179:00 amRNSBlock listing Interim Review
6th Mar 20177:00 amRNSNew drug discovery collaboration with Servier
28th Feb 20177:00 amRNSTotal Voting Rights
21st Feb 20177:00 amRNSUnaudited interim results for 6 months to 31/12/16
14th Feb 20177:00 amRNSAchievement of a $3m milestone payment from Corvus
30th Jan 201712:36 pmRNSNotice of Results for Six Months Ended 31/12/2016
21st Dec 20167:00 amRNSFDA accepts CCP-08 NDA for full review
1st Dec 20161:00 pmRNSVernalis Results of Annual General Meeting
1st Dec 20167:00 amRNSAGM Statement
3rd Nov 20164:36 pmRNSHolding(s) in Company
31st Oct 20167:00 amRNSTotal Voting Rights
24th Oct 20169:43 amRNSNotice of Annual Report and AGM
13th Oct 201611:58 amRNSHolding(s) in Company
12th Oct 20164:58 pmRNSDirector/PDMR Shareholding
12th Oct 20164:57 pmRNSDirector/PDMR Shareholding
5th Oct 20162:00 pmRNSHolding(s) in Company
5th Oct 20161:02 pmRNSHolding(s) in Company
30th Sep 20163:55 pmRNSDirector/PDMR Shareholding
29th Sep 20163:00 pmRNSBlock listing Interim Review
29th Sep 20167:00 amRNSResults Announcement for 12 months ended 30/06/16
22nd Sep 20161:43 pmRNSHolding(s) in Company
14th Sep 201610:54 amRNSHolding(s) in Company
13th Sep 201610:34 amRNSNotice of Results
6th Sep 20167:00 amRNSFDA accepts CCP-07 NDA for full review
29th Jul 20167:00 amRNSTotal Voting Rights
26th Jul 201612:53 pmRNSHolding(s) in Company
19th Jul 20167:00 amRNSVernalis Achieves Oncology Milestone with Servier
15th Jul 20167:00 amRNSVernalis Notes RedoxTherapies Acquisition by Juno
8th Jul 20167:00 amRNSVernalis Announce CCP-08 Multiple-Dose Results
7th Jul 20161:47 pmRNSYear-end Trading Update and Notice of Results
30th Jun 20167:00 amRNSTotal Voting Rights
24th Jun 20163:52 pmRNSHolding(s) in Company
9th Jun 20162:58 pmRNSDirector Dealing
31st May 20167:00 amRNSTotal Voting Rights
19th May 20164:11 pmRNSMoxatag Supply Update
16th May 20162:44 pmRNSHolding(s) in Company
12th May 201611:10 amRNSResults of General Meeting
29th Apr 20167:00 amRNSTotal Voting Rights
27th Apr 20164:40 pmRNSHolding(s) in Company
26th Apr 20165:17 pmRNSPosting of Circular and Notice of General Meeting
26th Apr 201611:00 amRNSVernalis plc to raise £40 million in Placing
21st Apr 20162:26 pmRNSSandford Sommer appointed as President & COO in US
14th Apr 20167:00 amRNSVernalis Announce CCP-07 Multiple-Dose Results
13th Apr 20167:00 amRNSVernalis Announce CCP-08 Single-Dose Study Results
31st Mar 20169:00 amRNSTotal Voting Rights
29th Mar 20161:55 pmRNSBlocklisting Interim Review
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
LTI
Lindsell Train
LSE
0.00%
PCFT
Polar Cap Gbl
LSE
-0.63%
PIN
Pantheon International
LSE
-0.26%
KBC
KBC.L
LSE
0.00%
KAZ
KAZ.L
LSE
0.00%
Trending
HEX
Helix Exploration
LSE
-1.89%
FORG
Forgent
LSE
9.09%
ORCP
Oracle Power
LSE
-9.09%
GST
GSTechnologies
LSE
5.88%
GGP
Greatland Resources
LSE
0.17%